Get startedLog in
    Picture of Prometheus Biosciences logo

    RXDX — Prometheus Biosciences News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeLarge Cap
    All News

    Brief: Prometheus Biosciences Provides Enrollment Update In Apollo-Cd And Artemis-Uc Global Phase 2 Studies

    Picture of Prometheus Biosciences logoPrometheus Biosciences
    08/06/2022 13:24
    June 8 (Reuters) - Prometheus Biosciences Inc  RXDX.O :
    * PROMETHEUS BIOSCIENCES PROVIDES ENROLLMENT UPDATE IN
APOLLO-CD
AND ARTEMIS-UC GLOBAL PHASE 2 STUDIES
    * PROMETHEUS BIOSCIENCES INC - ENROLLMENT COMPLETED AHEAD OF
SCHEDULE FOR APOLLO-CD PHASE 2A STUDY OF PRA023 IN CROHN'S
DISEASE PATIENTS
    * PROMETHEUS BIOSCIENCES INC - ARTEMIS-UC PHASE 2 COHORT 1
ENROLLMENT ON TRACK WITH COMPLETION EXPECTED 3Q 2022
    * PROMETHEUS BIOSCIENCES INC - BOTH APOLLO-CD AND ARTEMIS-UC
TOPLINE RESULTS EXPECTED 4Q 2022

Source text for Eikon:  ID:nGNX9GxrN5 
Further company coverage:  RXDX.O 

 ((reuters.briefs@thomsonreuters.com;))

    Recent news on Prometheus Biosciences

    See all news